2003 House Bill 5176 / 2004 Public Act 215

Show analysis

Introduced in the House

Oct. 15, 2003

Introduced by Rep. David Farhat (R-91)

To provide sentencing guidelines for the increased penalties proposed by House Bills 5174 and 5175 for adulterating, misbranding or substituting a drug or medical device for the purpose of defrauding or harming another person.

Referred to the Committee on Criminal Justice

Feb. 18, 2004

Reported without amendment

With the recommendation that the substitute (H-2) be adopted and that the bill then pass.

Feb. 25, 2004

Substitute offered

To replace the previous version of the bill with one containing technical changes that do not affect its substance as previously described.

The substitute passed by voice vote

Passed in the House 105 to 0 (details)

Received in the Senate

Feb. 26, 2004

Referred to the Committee on Judiciary

June 24, 2004

Reported without amendment

With the recommendation that the substitute (S-2) be adopted and that the bill then pass.

June 29, 2004

Substitute offered

To replace the previous version of the bill with one containing technical changes that do not affect its substance as previously described.

The substitute passed by voice vote

June 30, 2004

Passed in the Senate 36 to 0 (details)

To provide sentencing guidelines for the increased penalties proposed by House Bills 5174 and 5175 for adulterating, misbranding or substituting a drug or medical device for the purpose of defrauding or harming another person.

Received in the House

June 30, 2004

Passed in the House 104 to 0 (details)

To concur with the Senate-passed version of the bill.

Signed by Gov. Jennifer Granholm

July 14, 2004